Dr Lisa Huddlestone joins as Research Analyst
We’re delighted to welcome Lisa Huddlestone, PhD to the team as a Research Analyst and Zinc NIHR Innovation Fellow! Lisa holds a PhD in Epidemiology and Public Health from the University of Nottingham and brings over a decade of experience in developing and evaluating technologies to improve both physical and mental health outcomes. Her expertise …
CLCC at Essity
It’s been a superb 2 days in Munich at the office overlooking the alps of Essity – one of the world’s leading health and hygiene companies 🇸🇪. Beyond the stunning views, it was very powerful and poignant to get a deep dive into how a $15B+ revenue company truly thinks about and integrates innovation. Some …
CLCC presents at LSI Europe
LSI Europe ‘25 starts tomorrow! I’m looking forward to speaking about Calla Lily Clinical Care on Monday. LSI Europe brings together the world’s top medtech and healthtech innovators, investors, and strategics to discuss the bold ideas and breakthroughs shaping the future of healthcare.
CLCC takes part in the Innovate UK & Texas Medical Center Innovation Factory accelerator
Growing up in Houston it’s easy to get used to the shear size and impact of our medical center, which is the largest in the world! But being here this week has reminded how extraordinary it really is. 🌎🏥 This is the 3rd year of the Innovate UK & Texas Medical Center Innovation Factory accelerator, …
CLCC presents at 34th Singapore Pharmacy Congress
Honoured to be speaking at the 34th Singapore Pharmacy Congress 🇸🇬 to share the development journey and translational strategy behind our Callavid® vaginal drug delivery platform. Calla Lily Clinical Care is focused on advancing a patient centric solution that delivers targeted and user-friendly therapies for conditions with high unmet clinical need. I’ll be sharing our …
Miscarriage Prevention: Science, Gaps, and the Path Forward
One in 5. Look around the room. If you are at a conference with 100 women, statistics tell us that as many as 20 of them will have had a miscarriage at some point. That means miscarriage is common, but that doesn’t make it easy. And it definitely doesn’t mean we should accept it as …
CLCC MIT contingent at the Venture Cafe / MISTI event
It’s a real privilege to be working alongside three brilliant Massachusetts Institute of Technology engineers at Calla Lily Clinical Care. We had a great time yesterday at the summer reception hosted by MIT International Science & Technology Initiatives (MISTI) at the impressive new Venture Café London, the first Venture Café Global Institute to open in …
CLCC Hosts Zinc Innovation Fellowship Cohort
Every month, Zinc Innovation Fellows – a cohort of clinicians and researchers gaining hands-on innovation skills in ventures – attend cohort days to learn relevant skills and knowledge that support their innovation development. Today’s cohort day was extra special as it was delivered by Thang Vo-Ta at Calla Lily Clinical Care, one of the programme’s …
CLCC at Innovate UK Panel: Breaking into New International Markets
All smiles from our panel on “Breaking into New International Markets” at the Innovate UK Innovate Local: South East business event held at Royal Holloway, University of London. Fellow CEO Harsha Siani and I shared our experiences taking part in Innovate UK’s Global Business Innovation Programmes (GBIPs) across Sweden, Switzerland, and the U.S. 🇸🇪 🇨🇭 …
“Ozempic Babies” and Menopause
The British menopause society has recently released guidance that women using the ever-so-popular GLP-1 agonists such as Ozempic & Mounjaro, and who are also taking oral progesterone for endometrial protection – should probably be switched to a transdermal or vaginal versions of progesterone. Why? I’ll try to explain via the “cutesy” hashtag making its way …